MedTrace Logo

Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation

NCT05244356 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5784

Last updated 2022-02-17

No results posted yet for this study

Summary

This is a randomised controlled experiment in the form of a web based survey study which randomly exposes participants to different forms of public health messages, after which participants will be assessed on their intent to take up the COVID-19 vaccine, recommend the vaccine, and also willingness to propagate the exposed message.

Conditions

  • COVID-19
  • Respiratory Disease
  • Vaccine Refusal
  • Infectious Disease
  • Coronavirus Infections
  • Behavior, Health
  • Pneumonia
  • Respiratory Tract Infections
  • Lung Diseases
  • Pneumonia, Viral

Interventions

BEHAVIORAL

Health message exposure

Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Sponsors & Collaborators

  • Institute for Health Behavioral Research, Malaysia

    collaborator UNKNOWN

  • University of Malaya

    collaborator OTHER

  • UNICEF Malaysia

    collaborator UNKNOWN

  • Ministry of Health, Malaysia

    collaborator OTHER_GOV

  • London School of Economics and Political Science

    collaborator OTHER

  • Clinical Research Centre, Malaysia

    lead OTHER

Principal Investigators

  • Yee Liang Hing, MSc. · Clinical Research Centre, Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-29
Primary Completion
2021-06-07
Completion
2021-06-07

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05244356 on ClinicalTrials.gov